Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistente

Detalhes bibliográficos
Autor(a) principal: Cavalcanti, Bruno Bezerra
Data de Publicação: 2021
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UFPB
Texto Completo: https://repositorio.ufpb.br/jspui/handle/123456789/23386
Resumo: Candidiasis or oral candidiasis is a disease most commonly caused by Candida albicans, present in the microbiota as commensals, it is an opportunistic infection being observed mainly in immunocompromised patients. It is estimated that approximately 50% of the healthy population carries Candida species in the oral cavity. In the treatment of mild oral candidiasis, azole or polyene antifungals are highlighted. The adverse effects and cost of conventional antifungal treatment have led to the search for new drugs, one of the alternatives being terpenes. Extracted from essential oils are complex mixtures of various compounds, myrtenol being an example. In this work, the activity of myrtenol against fluconazole resistant Candida strains was verified. Minimum inhibitory concentration, minimum fungicidal concentration, in addition to modulation and association studies (checkerboard method) were performed via the microdilution technique. With the strains tested, myrtenol demonstrated minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) at concentrations of 512 μg/mL, so it has weak antifungal activity and is fungicidal. In the assay of modulation of myrtenol in subinhibitory concentration with the main antifungal agents, there was an increase in the MIC of these drugs. When myrtenol was associated with these antifungal agents (checkboard method), synergistic or indifferent results were observed with fluconazole or amphotericin B, respectively. Myrtenol has weak antifungal activity against the strains tested, but with a fungicidal characteristic, it does not increase the activity of fluconazole and amphotericin B and, in association with conventional antifungal agents, it showed a synergistic or indifferent effect depending on the strain tested.
id UFPB_29c21cba5e90276ef59c55948abfb4cb
oai_identifier_str oai:repositorio.ufpb.br:123456789/23386
network_acronym_str UFPB
network_name_str Biblioteca Digital de Teses e Dissertações da UFPB
repository_id_str
spelling Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistenteCandidíase bucalProdutos naturaisMonoterpenosOral candidiasisNatural productsMonoterpenesCNPQ::CIENCIAS DA SAUDE::ODONTOLOGIACandidiasis or oral candidiasis is a disease most commonly caused by Candida albicans, present in the microbiota as commensals, it is an opportunistic infection being observed mainly in immunocompromised patients. It is estimated that approximately 50% of the healthy population carries Candida species in the oral cavity. In the treatment of mild oral candidiasis, azole or polyene antifungals are highlighted. The adverse effects and cost of conventional antifungal treatment have led to the search for new drugs, one of the alternatives being terpenes. Extracted from essential oils are complex mixtures of various compounds, myrtenol being an example. In this work, the activity of myrtenol against fluconazole resistant Candida strains was verified. Minimum inhibitory concentration, minimum fungicidal concentration, in addition to modulation and association studies (checkerboard method) were performed via the microdilution technique. With the strains tested, myrtenol demonstrated minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) at concentrations of 512 μg/mL, so it has weak antifungal activity and is fungicidal. In the assay of modulation of myrtenol in subinhibitory concentration with the main antifungal agents, there was an increase in the MIC of these drugs. When myrtenol was associated with these antifungal agents (checkboard method), synergistic or indifferent results were observed with fluconazole or amphotericin B, respectively. Myrtenol has weak antifungal activity against the strains tested, but with a fungicidal characteristic, it does not increase the activity of fluconazole and amphotericin B and, in association with conventional antifungal agents, it showed a synergistic or indifferent effect depending on the strain tested.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESA candidíase ou candidíase oral é uma doença causada mais comumente pela Candida albicans, presentes na microbiota como comensais, é uma infecção oportunista sendo observada principalmente em pacientes imunocomprometidos. Estima-se que aproximadamente 50% da população saudável carrega espécies de Candida na cavidade oral. Na terapêutica das candidíases orais leves destacam-se antifúngicos azólicos ou poliênicos. Os efeitos adversos e custo do tratamento dos antifúngicos convencionais tem levado a busca de novos fármacos, uma das alternativas são os terpenos. Extraídos dos óleos essenciais são misturas complexas de vários compostos, sendo o mirtenol um exemplo. Nesse trabalho verificou-se a atividade do mirtenol contra cepas de Candida resistentes ao fluconazol. Foi realizada a concentração inibitória mínima, concentração fungicida mínima, além dos estudos de modulação e de associação (método checkerboard), via técnica de microdiluição. Com as cepas testadas, o mirtenol demostrou a concentração inibitória mínima (CIM) e a concentração fungicida mínima (CFM) nas concentrações de 512 μg/mL, logo este possui fraca atividade antifúngica e esta tem caráter fungicida. No ensaio de modulação do mirtenol em concentração subinibitória com os principais antifúngicos houve aumento da CIM destes fármacos. Quando se associou o mirtenol com estes antifúngicos (método checkboard), observou-se resultados sinérgicos ou indiferentes com o fluconazol ou a anfotericina B, respectivamente. O mirtenol possui fraca atividade antifúngica frente as cepas ensaiadas, porém com característica fungicida, ele não aumenta a atividade do fluconazol e anfotericina B e em associação com antifúngicos convencionais demonstrou efeito sinérgico ou indiferente dependendo da cepa ensaiada.Universidade Federal da ParaíbaBrasilOdontologiaPrograma de Pós-Graduação em OdontologiaUFPBGuerra, Felipe Queiroga Sarmentohttp://lattes.cnpq.br/4997951182162954Sampaio, Fábio Correiahttp://lattes.cnpq.br/7549914789004407Cavalcanti, Bruno Bezerra2022-07-11T16:52:09Z2021-10-192022-07-11T16:52:09Z2021-08-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesishttps://repositorio.ufpb.br/jspui/handle/123456789/23386porAttribution-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nd/3.0/br/info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UFPBinstname:Universidade Federal da Paraíba (UFPB)instacron:UFPB2022-08-09T12:48:01Zoai:repositorio.ufpb.br:123456789/23386Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufpb.br/PUBhttp://tede.biblioteca.ufpb.br:8080/oai/requestdiretoria@ufpb.br|| diretoria@ufpb.bropendoar:2022-08-09T12:48:01Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)false
dc.title.none.fl_str_mv Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistente
title Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistente
spellingShingle Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistente
Cavalcanti, Bruno Bezerra
Candidíase bucal
Produtos naturais
Monoterpenos
Oral candidiasis
Natural products
Monoterpenes
CNPQ::CIENCIAS DA SAUDE::ODONTOLOGIA
title_short Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistente
title_full Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistente
title_fullStr Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistente
title_full_unstemmed Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistente
title_sort Avaliação atividade antifúngica do mirtenol frente Candida albicans E Candida parapsilosis fluconazol resistente
author Cavalcanti, Bruno Bezerra
author_facet Cavalcanti, Bruno Bezerra
author_role author
dc.contributor.none.fl_str_mv Guerra, Felipe Queiroga Sarmento
http://lattes.cnpq.br/4997951182162954
Sampaio, Fábio Correia
http://lattes.cnpq.br/7549914789004407
dc.contributor.author.fl_str_mv Cavalcanti, Bruno Bezerra
dc.subject.por.fl_str_mv Candidíase bucal
Produtos naturais
Monoterpenos
Oral candidiasis
Natural products
Monoterpenes
CNPQ::CIENCIAS DA SAUDE::ODONTOLOGIA
topic Candidíase bucal
Produtos naturais
Monoterpenos
Oral candidiasis
Natural products
Monoterpenes
CNPQ::CIENCIAS DA SAUDE::ODONTOLOGIA
description Candidiasis or oral candidiasis is a disease most commonly caused by Candida albicans, present in the microbiota as commensals, it is an opportunistic infection being observed mainly in immunocompromised patients. It is estimated that approximately 50% of the healthy population carries Candida species in the oral cavity. In the treatment of mild oral candidiasis, azole or polyene antifungals are highlighted. The adverse effects and cost of conventional antifungal treatment have led to the search for new drugs, one of the alternatives being terpenes. Extracted from essential oils are complex mixtures of various compounds, myrtenol being an example. In this work, the activity of myrtenol against fluconazole resistant Candida strains was verified. Minimum inhibitory concentration, minimum fungicidal concentration, in addition to modulation and association studies (checkerboard method) were performed via the microdilution technique. With the strains tested, myrtenol demonstrated minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) at concentrations of 512 μg/mL, so it has weak antifungal activity and is fungicidal. In the assay of modulation of myrtenol in subinhibitory concentration with the main antifungal agents, there was an increase in the MIC of these drugs. When myrtenol was associated with these antifungal agents (checkboard method), synergistic or indifferent results were observed with fluconazole or amphotericin B, respectively. Myrtenol has weak antifungal activity against the strains tested, but with a fungicidal characteristic, it does not increase the activity of fluconazole and amphotericin B and, in association with conventional antifungal agents, it showed a synergistic or indifferent effect depending on the strain tested.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-19
2021-08-30
2022-07-11T16:52:09Z
2022-07-11T16:52:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.ufpb.br/jspui/handle/123456789/23386
url https://repositorio.ufpb.br/jspui/handle/123456789/23386
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Odontologia
Programa de Pós-Graduação em Odontologia
UFPB
publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Odontologia
Programa de Pós-Graduação em Odontologia
UFPB
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFPB
instname:Universidade Federal da Paraíba (UFPB)
instacron:UFPB
instname_str Universidade Federal da Paraíba (UFPB)
instacron_str UFPB
institution UFPB
reponame_str Biblioteca Digital de Teses e Dissertações da UFPB
collection Biblioteca Digital de Teses e Dissertações da UFPB
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)
repository.mail.fl_str_mv diretoria@ufpb.br|| diretoria@ufpb.br
_version_ 1801842995890225152